ES2373428T3 - Infidelidad de la transcripción, su detección y sus usos. - Google Patents

Infidelidad de la transcripción, su detección y sus usos. Download PDF

Info

Publication number
ES2373428T3
ES2373428T3 ES07787788T ES07787788T ES2373428T3 ES 2373428 T3 ES2373428 T3 ES 2373428T3 ES 07787788 T ES07787788 T ES 07787788T ES 07787788 T ES07787788 T ES 07787788T ES 2373428 T3 ES2373428 T3 ES 2373428T3
Authority
ES
Spain
Prior art keywords
protein
sequence
transcription
infidelity
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES07787788T
Other languages
English (en)
Spanish (es)
Inventor
Bernard Bihain
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Transmedi SA
Original Assignee
Transmedi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transmedi SA filed Critical Transmedi SA
Application granted granted Critical
Publication of ES2373428T3 publication Critical patent/ES2373428T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Glass Compositions (AREA)
  • Pit Excavations, Shoring, Fill Or Stabilisation Of Slopes (AREA)
  • Peptides Or Proteins (AREA)
ES07787788T 2006-07-20 2007-07-20 Infidelidad de la transcripción, su detección y sus usos. Active ES2373428T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP06291176 2006-07-20
EP06291176A EP1887088A1 (en) 2006-07-20 2006-07-20 Transcription infidelity, detection and uses thereof
PCT/EP2007/057541 WO2008009751A2 (en) 2006-07-20 2007-07-20 Transcription infidelity, detection and uses thereof

Publications (1)

Publication Number Publication Date
ES2373428T3 true ES2373428T3 (es) 2012-02-03

Family

ID=37496681

Family Applications (2)

Application Number Title Priority Date Filing Date
ES07787788T Active ES2373428T3 (es) 2006-07-20 2007-07-20 Infidelidad de la transcripción, su detección y sus usos.
ES11173357.2T Active ES2553435T3 (es) 2006-07-20 2007-07-20 Infidelidad de la transcripción, su detección y sus usos

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES11173357.2T Active ES2553435T3 (es) 2006-07-20 2007-07-20 Infidelidad de la transcripción, su detección y sus usos

Country Status (18)

Country Link
US (1) US8288091B2 (enExample)
EP (3) EP1887088A1 (enExample)
JP (1) JP5298013B2 (enExample)
KR (1) KR101502179B1 (enExample)
AT (1) ATE524565T1 (enExample)
AU (1) AU2007275068B2 (enExample)
BR (1) BRPI0714563B8 (enExample)
CA (1) CA2658305C (enExample)
CY (2) CY1112125T1 (enExample)
DK (2) DK2046986T3 (enExample)
ES (2) ES2373428T3 (enExample)
HU (1) HUE028135T2 (enExample)
IL (1) IL196600A0 (enExample)
PL (2) PL2046986T3 (enExample)
PT (2) PT2046986E (enExample)
SI (2) SI2468885T1 (enExample)
TR (1) TR201112295Y (enExample)
WO (1) WO2008009751A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2071334A1 (en) * 2007-12-14 2009-06-17 Transmedi SA Compositions and methods of detecting TIABS
EP2080812A1 (en) 2008-01-18 2009-07-22 Transmedi SA Compositions and methods of detecting post-stop peptides
EP2995688A1 (en) 2014-09-12 2016-03-16 Genclis Methods of prognosing and treating triple negative breast cancer
WO2017100789A1 (en) * 2015-12-11 2017-06-15 Expression Pathology, Inc. Srm/mrm assays
LT3430390T (lt) 2016-03-18 2022-11-25 Genclis Molekulinė alergijos kilmė
WO2018187216A1 (en) * 2017-04-03 2018-10-11 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Expression cassettes and methods for detecting transcription errors
EP3700856A4 (en) 2017-10-26 2021-12-15 Ultima Genomics, Inc. METHODS AND SYSTEMS FOR SEQUENCE CALL
CN113795887A (zh) 2019-03-10 2021-12-14 阿尔缇玛基因组学公司 用于序列判定的方法和系统
WO2021030271A2 (en) 2019-08-09 2021-02-18 Nutcracker Therapeutics, Inc. Methods and apparatuses for manufacturing for removing material from a therapeutic composition
KR102334576B1 (ko) * 2019-08-12 2021-12-07 한국생명공학연구원 융합 단백질 및 이를 포함하는 바이오 이미징용 조성물
EP4211268A4 (en) * 2020-09-10 2024-09-18 Ultima Genomics, Inc. SEQUENCE AND VARIANT CALLING METHODS AND SYSTEMS
WO2022108309A1 (ko) * 2020-11-18 2022-05-27 한양대학교 에리카산학협력단 인산화된 비멘틴의 과도한 생성을 차단하여 암을 예방 또는 치료하는 방법
EP4162948A1 (en) 2021-10-05 2023-04-12 Genclis Transcription infidelity derived chimeric immunogens and uses thereof
WO2023104904A2 (en) 2021-12-08 2023-06-15 Genclis The sars-cov-2 and variants use two independent cell receptors to replicate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4979330A (en) 1989-10-10 1990-12-25 Rorant Julius W Suction insect trap device
US6120992A (en) 1993-11-04 2000-09-19 Valigene Corporation Use of immobilized mismatch binding protein for detection of mutations and polymorphisms, and allele identification in a diseased human
WO2001040804A2 (en) * 1999-12-03 2001-06-07 Koninklijke Nederlandse Akademie Van Wetenschappen Clearance of aberrant protein in correlation with disease
US20020132259A1 (en) 2001-02-21 2002-09-19 Wagner Robert E. Mutation detection using MutS and RecA
WO2006053061A2 (en) * 2004-11-10 2006-05-18 Kansas State University Research Foundation Porcine reproductive and respiratory syndrome virus receptor components and uses thereof

Also Published As

Publication number Publication date
BRPI0714563A2 (pt) 2015-04-14
JP2009544284A (ja) 2009-12-17
HK1128937A1 (en) 2009-11-13
DK2046986T3 (da) 2012-01-02
PL2468885T3 (pl) 2016-04-29
KR101502179B1 (ko) 2015-03-12
CY1112125T1 (el) 2015-11-04
AU2007275068A1 (en) 2008-01-24
US8288091B2 (en) 2012-10-16
CA2658305C (en) 2017-07-18
TR201112295Y (tr) 2018-08-27
BRPI0714563B1 (pt) 2019-07-02
SI2468885T1 (sl) 2016-02-29
SI2046986T1 (sl) 2012-05-31
EP2468885A2 (en) 2012-06-27
WO2008009751A3 (en) 2008-07-31
DK2468885T3 (da) 2016-02-29
CY1116939T1 (el) 2017-04-05
US20090317386A1 (en) 2009-12-24
AU2007275068B2 (en) 2013-06-06
BRPI0714563B8 (pt) 2021-05-25
JP5298013B2 (ja) 2013-09-25
WO2008009751A2 (en) 2008-01-24
EP2468885B1 (en) 2015-08-19
ATE524565T1 (de) 2011-09-15
CA2658305A1 (en) 2008-01-24
HUE028135T2 (en) 2016-12-28
EP2046986A2 (en) 2009-04-15
IL196600A0 (en) 2009-11-18
KR20090052861A (ko) 2009-05-26
EP2046986B1 (en) 2011-09-14
EP1887088A1 (en) 2008-02-13
ES2553435T3 (es) 2015-12-09
PL2046986T3 (pl) 2012-02-29
EP2468885A3 (en) 2012-08-29
PT2046986E (pt) 2011-12-29
PT2468885E (pt) 2015-11-26

Similar Documents

Publication Publication Date Title
ES2373428T3 (es) Infidelidad de la transcripción, su detección y sus usos.
Ma et al. Proteogenomic characterization and comprehensive integrative genomic analysis of human colorectal cancer liver metastasis
Du et al. Chromatin interactions and candidate genes at ten prostate cancer risk loci
Gao et al. Rare coding variants in MAPK7 predispose to adolescent idiopathic scoliosis
WO2020191521A1 (zh) 核酸序列、rna目标区域测序文库的构建方法及应用
WO2023221308A1 (zh) 一种液相杂交捕获方法及其试剂盒
CN105132409A (zh) RNA 5mC重亚硫酸盐测序的文库构建方法及其应用
JP2011517937A (ja) 体細胞性及び卵巣癌の診断のためのインビトロ診断方法
Teles Alves et al. Next-generation sequencing reveals novel rare fusion events with functional implication in prostate cancer
Gielniewski et al. Targeted sequencing of cancer‐related genes reveals a recurrent TOP2A variant which affects DNA binding and coincides with global transcriptional changes in glioblastoma
CN104830972B (zh) 前列腺癌的生物学标志物、治疗靶点及其用途
Chen et al. CD2AP is a potential prognostic biomarker of renal clear cell carcinoma
Jonchère et al. Microsatellite instability at U2AF-binding polypyrimidic tract sites perturbs alternative splicing during colorectal cancer initiation
KR20150085459A (ko) 대장암 마커로서의 신규 ntrk1 융합유전자 및 이의 용도
CN114480632A (zh) 人微卫星不稳定位点的检测方法及其应用
HK1128937B (en) Transcription infidelity, detection and uses thereof
Valletti et al. Identification of tumor-associated cassette exons in human cancer through EST-based computational prediction and experimental validation
WO2024194255A1 (en) Long-read sequencing of human immunoglobulin gene introns to define a biomarker for in vivo dna break repair
Pećina-Šlaus et al. Microsatellite instability as a driving force for cancer progression
CN119242803A (zh) 一种检测白血病患者dna结构变异区域的方法及其应用
CN120775981A (zh) 检测癌症微卫星不稳定性的生物标志物、试剂盒及应用
CN114277128A (zh) 一种染色体9p21.3缺失在辅助诊断和预后脊索瘤中的应用
CN114277130A (zh) 一种染色体9q21.11缺失在辅助诊断和预后脊索瘤中的应用
HK1192279A (en) Prostate cancer biomarkers, therapeutic targets and uses thereof
Marzellíusardóttir Search for influential genomic changes in breast cancer families